Clinical trial
Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of…
NCT00294112 · Mesoblast, Inc., Industry · Completed
Key facts
| NCT number | NCT00294112 |
|---|---|
| Title | Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease |
| Official title | A Phase II, Open-label, Randomized Study to Evaluate the Safety and Efficacy of PROCHYMAL™ IBD (ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Intravenous Infusion for the Treatment of Subjects Experiencing Moderate-to-severe Crohn's Disease That is Refractory to Steroids and Immune… |
| Lead sponsor | Mesoblast, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Drug |
| Interventions | Prochymal™ adult human mesenchymal stem cells, adult human mesenchymal stem cells |
| Enrollment | 10 |
| Start date | Mar 13, 2006 |
| Primary completion | Jul 21, 2006 |
| Completion | Jul 21, 2006 |
| First posted | Feb 20, 2006 |
| Last update posted | Apr 2, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: